Search - tctmd.com

Displaying 141 - 160 of 390

Sort: Relevancy | Date

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Presentation TCT 2019

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Presenter: Seung-Jung Park

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

Presenter: Ron Waksman

September 27, 2019

Presentation TCT 2019

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

Presenter: Francesco Prati

September 27, 2019

Presentation TCT 2019

Keynote Lecture: The Thirty-Year Search for the Vulnerable Plaque — Pursuit of the Holy Grail or a Fool’s Errand?

Presenter: James Muller

September 27, 2019

Presentation TCT 2019

TCT 16: Longitudinal Distribution of Lipid Rich Plaque in Nonculprit Lesions: A Lipid Rich Plaque (LRP) Study Sub-analysis

Presenter: Evan Shlofmitz

September 25, 2019

Presentation TCT 2019

TCT 15: Prognostic Impact of Healed Coronary Plaque in Non-culprit Segments Assessed by Optical Coherence Tomography

Presenter: Eisuke Usui

September 25, 2019

Presentation TCT 2019

TCT 14: Assessment of the Sources of Near-infrared Auto-fluorescence in High-risk Coronary Artery Plaques: a Histopathologic Correlative Study

Presenter: Mie Kunio

September 25, 2019

Presentation TCT 2019

TCT 13: Alirocumab improve coronary plaque vulnerability: first randomized control trial to assess the effect of alirocumab for plaque vulnerabilityusing optical coherence tomography.

Presenter: yoichiro sugizaki

September 25, 2019

Presentation TCT 2019

TCT 12: Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

Presenter: Christoph Garlichs

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation TCT 2019

TCT 10: Time and Mortality in ST Elevation Myocardial Infarction: Insights From the TOTAL Trial

Presenter: Rachel Moxham

September 25, 2019

Presentation TCT 2019

TCT 9: Quantitative Assessment of Lipid Composition by NIRS-IVUS Is Helpful for Differentiating among Plaque Rupture, Plaque Erosion and Calcified Nodule in the Culprit Lesion of ACS

Presenter: Kosei Terada

September 25, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News EuroPCR 2019

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Shelley Wood

May 22, 2019

Presentation OPCI 2019

Detection of vulnerable and lipid-rich plaque using NIRS and other technologies – Is this the future?

Presenter: Ron Waksman

March 09, 2019

Presentation JIM 2019

MACE prediction: exploring IVUS+NIRS imaging and the LRP study results

Presenter: Francesco Prati

February 14, 2019

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Conference News TCT 2018

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Yael L. Maxwell

September 24, 2018

Advertisement

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

IVUS and OCT Imaging for the Detection of Vulnerable Plaque and Patients

Keynote Lecture: The Thirty-Year Search for the Vulnerable Plaque — Pursuit of the Holy Grail or a Fool’s Errand?

TCT 16: Longitudinal Distribution of Lipid Rich Plaque in Nonculprit Lesions: A Lipid Rich Plaque (LRP) Study Sub-analysis

TCT 15: Prognostic Impact of Healed Coronary Plaque in Non-culprit Segments Assessed by Optical Coherence Tomography

TCT 14: Assessment of the Sources of Near-infrared Auto-fluorescence in High-risk Coronary Artery Plaques: a Histopathologic Correlative Study

TCT 13: Alirocumab improve coronary plaque vulnerability: first randomized control trial to assess the effect of alirocumab for plaque vulnerabilityusing optical coherence tomography.

TCT 12: Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

TCT 10: Time and Mortality in ST Elevation Myocardial Infarction: Insights From the TOTAL Trial

TCT 9: Quantitative Assessment of Lipid Composition by NIRS-IVUS Is Helpful for Differentiating among Plaque Rupture, Plaque Erosion and Calcified Nodule in the Culprit Lesion of ACS

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Detection of vulnerable and lipid-rich plaque using NIRS and other technologies – Is this the future?

MACE prediction: exploring IVUS+NIRS imaging and the LRP study results

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content